Phase Ib of L-NMMA and Pembrolizumab
The Methodist Hospital Research Institute
The Methodist Hospital Research Institute
Merck Sharp & Dohme LLC
Sotio Biotech Inc.
M.D. Anderson Cancer Center
Emory University
MacroGenics
University of California, Davis
Kezar Life Sciences, Inc.
Tempus AI
Pfizer
Day One Biopharmaceuticals, Inc.
Merck Sharp & Dohme LLC
Incyte Corporation
Hoffmann-La Roche
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Incyte Corporation
MacroGenics
Yale University
MacroGenics
NRG Oncology
NGM Biopharmaceuticals, Inc
Mural Oncology, Inc
Seagen Inc.
Kymab Limited
Shattuck Labs, Inc.
Syndax Pharmaceuticals
Incyte Corporation
GlaxoSmithKline
Seagen Inc.
Sarcoma Oncology Research Center, LLC
BerGenBio ASA
Stanford University
National Cancer Institute (NCI)
Rain Oncology Inc
Novartis
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
GlaxoSmithKline
National Cancer Institute (NCI)
Pfizer
Haihe Biopharma Co., Ltd.
Pfizer
ADC Therapeutics S.A.
Exelixis
Pfizer
Eli Lilly and Company
Memorial Sloan Kettering Cancer Center
NextCure, Inc.
Apexigen America, Inc.
Novartis